Histomorphometric comparison of different concentrations of recombinant human bone morphogenetic protein with allogeneic bone compared to the use of 100% mineralized cancellous bone allograft in maxillary sinus grafting

Stuart J. Froum, Stephen Wallace, Sang Choon Cho, Ismael Khouly, Edwin Rosenberg, Patricia Corby, Scott Froum, Timothy Bromage, Robert Schoor, Robert Norman, Dennis P. Tarnow

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to histomorphometrically evaluate the percentage of vital bone after grafting of maxillary sinuses using two different concentrations of recombinant human bone morphogenetic protein/acellular collagen sponge (rhBMP-2/ACS) combined with mineralized cancellous bone allograft (MCBA) and to compare the results to a control sinus grafted with MCBA only. Thirty-six sinuses in 18 patients had two of three of the graft combinations including: (1) control, MCBA only; (2) test one, MCBA + 5.6 mL of rhBMP-2/ACS (containing 8.4 mg of rhBMP-2); or (3) test two, MCBA + 2.8 mL of rhBMP-2/ACS (containing 4.2 mg of rhBMP-2). Histologic cores were taken 6 to 9 month following sinus augmentation. The results showed no statistically significant differences in vital bone between the two test groups compared to the control sinus group treated with MCBA alone. Future studies involving more cases and evaluating survival of implants placed in these augmented sinuses are needed to verify the results of this randomized prospective study.

Original languageEnglish (US)
Pages (from-to)721-730
Number of pages10
JournalThe International journal of periodontics & restorative dentistry
Volume33
Issue number6
DOIs
StatePublished - Nov 1 2013

Fingerprint

Bone Morphogenetic Proteins
Maxillary Sinus
Allografts
Bone and Bones
Bone Transplantation
Porifera
Cancellous Bone
Collagen
Prospective Studies
Transplants
Control Groups
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Histomorphometric comparison of different concentrations of recombinant human bone morphogenetic protein with allogeneic bone compared to the use of 100% mineralized cancellous bone allograft in maxillary sinus grafting. / Froum, Stuart J.; Wallace, Stephen; Cho, Sang Choon; Khouly, Ismael; Rosenberg, Edwin; Corby, Patricia; Froum, Scott; Bromage, Timothy; Schoor, Robert; Norman, Robert; Tarnow, Dennis P.

In: The International journal of periodontics & restorative dentistry, Vol. 33, No. 6, 01.11.2013, p. 721-730.

Research output: Contribution to journalArticle

Froum, Stuart J. ; Wallace, Stephen ; Cho, Sang Choon ; Khouly, Ismael ; Rosenberg, Edwin ; Corby, Patricia ; Froum, Scott ; Bromage, Timothy ; Schoor, Robert ; Norman, Robert ; Tarnow, Dennis P. / Histomorphometric comparison of different concentrations of recombinant human bone morphogenetic protein with allogeneic bone compared to the use of 100% mineralized cancellous bone allograft in maxillary sinus grafting. In: The International journal of periodontics & restorative dentistry. 2013 ; Vol. 33, No. 6. pp. 721-730.
@article{263c8d98ad374aa2aef5198367cd8f2a,
title = "Histomorphometric comparison of different concentrations of recombinant human bone morphogenetic protein with allogeneic bone compared to the use of 100{\%} mineralized cancellous bone allograft in maxillary sinus grafting",
abstract = "The purpose of this study was to histomorphometrically evaluate the percentage of vital bone after grafting of maxillary sinuses using two different concentrations of recombinant human bone morphogenetic protein/acellular collagen sponge (rhBMP-2/ACS) combined with mineralized cancellous bone allograft (MCBA) and to compare the results to a control sinus grafted with MCBA only. Thirty-six sinuses in 18 patients had two of three of the graft combinations including: (1) control, MCBA only; (2) test one, MCBA + 5.6 mL of rhBMP-2/ACS (containing 8.4 mg of rhBMP-2); or (3) test two, MCBA + 2.8 mL of rhBMP-2/ACS (containing 4.2 mg of rhBMP-2). Histologic cores were taken 6 to 9 month following sinus augmentation. The results showed no statistically significant differences in vital bone between the two test groups compared to the control sinus group treated with MCBA alone. Future studies involving more cases and evaluating survival of implants placed in these augmented sinuses are needed to verify the results of this randomized prospective study.",
author = "Froum, {Stuart J.} and Stephen Wallace and Cho, {Sang Choon} and Ismael Khouly and Edwin Rosenberg and Patricia Corby and Scott Froum and Timothy Bromage and Robert Schoor and Robert Norman and Tarnow, {Dennis P.}",
year = "2013",
month = "11",
day = "1",
doi = "10.11607/prd.1736",
language = "English (US)",
volume = "33",
pages = "721--730",
journal = "The International journal of periodontics & restorative dentistry",
issn = "0198-7569",
publisher = "Quintessence Publishing Company",
number = "6",

}

TY - JOUR

T1 - Histomorphometric comparison of different concentrations of recombinant human bone morphogenetic protein with allogeneic bone compared to the use of 100% mineralized cancellous bone allograft in maxillary sinus grafting

AU - Froum, Stuart J.

AU - Wallace, Stephen

AU - Cho, Sang Choon

AU - Khouly, Ismael

AU - Rosenberg, Edwin

AU - Corby, Patricia

AU - Froum, Scott

AU - Bromage, Timothy

AU - Schoor, Robert

AU - Norman, Robert

AU - Tarnow, Dennis P.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - The purpose of this study was to histomorphometrically evaluate the percentage of vital bone after grafting of maxillary sinuses using two different concentrations of recombinant human bone morphogenetic protein/acellular collagen sponge (rhBMP-2/ACS) combined with mineralized cancellous bone allograft (MCBA) and to compare the results to a control sinus grafted with MCBA only. Thirty-six sinuses in 18 patients had two of three of the graft combinations including: (1) control, MCBA only; (2) test one, MCBA + 5.6 mL of rhBMP-2/ACS (containing 8.4 mg of rhBMP-2); or (3) test two, MCBA + 2.8 mL of rhBMP-2/ACS (containing 4.2 mg of rhBMP-2). Histologic cores were taken 6 to 9 month following sinus augmentation. The results showed no statistically significant differences in vital bone between the two test groups compared to the control sinus group treated with MCBA alone. Future studies involving more cases and evaluating survival of implants placed in these augmented sinuses are needed to verify the results of this randomized prospective study.

AB - The purpose of this study was to histomorphometrically evaluate the percentage of vital bone after grafting of maxillary sinuses using two different concentrations of recombinant human bone morphogenetic protein/acellular collagen sponge (rhBMP-2/ACS) combined with mineralized cancellous bone allograft (MCBA) and to compare the results to a control sinus grafted with MCBA only. Thirty-six sinuses in 18 patients had two of three of the graft combinations including: (1) control, MCBA only; (2) test one, MCBA + 5.6 mL of rhBMP-2/ACS (containing 8.4 mg of rhBMP-2); or (3) test two, MCBA + 2.8 mL of rhBMP-2/ACS (containing 4.2 mg of rhBMP-2). Histologic cores were taken 6 to 9 month following sinus augmentation. The results showed no statistically significant differences in vital bone between the two test groups compared to the control sinus group treated with MCBA alone. Future studies involving more cases and evaluating survival of implants placed in these augmented sinuses are needed to verify the results of this randomized prospective study.

UR - http://www.scopus.com/inward/record.url?scp=84943756074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943756074&partnerID=8YFLogxK

U2 - 10.11607/prd.1736

DO - 10.11607/prd.1736

M3 - Article

C2 - 24116356

AN - SCOPUS:84943756074

VL - 33

SP - 721

EP - 730

JO - The International journal of periodontics & restorative dentistry

JF - The International journal of periodontics & restorative dentistry

SN - 0198-7569

IS - 6

ER -